z-logo
open-access-imgOpen Access
Interleukin-12 supports in vitro self-renewal of long-term hematopoietic stem cells
Author(s) -
Shanshan Zhang,
Mamoru Morita,
Zhao Wang,
Jun Ooehara,
Sen Zhang,
Miner Xie,
Hao Bai,
Wenying Yu,
Xiaofang Wang,
Fang Dong,
Jinhong Wang,
Shihui Ma,
Satoshi Yamazaki,
Hideo Ema
Publication year - 2019
Publication title -
blood science
Language(s) - English
Resource type - Journals
ISSN - 2543-6368
DOI - 10.1097/bs9.0000000000000002
Subject(s) - stem cell factor , haematopoiesis , stem cell , thrombopoietin , microbiology and biotechnology , biology , in vitro , transplantation , immunology , cd34 , cytokine , cell division , cell , medicine , genetics
Hematopoietic stem cells (HSCs) self-renew or differentiate through division. Cytokines are essential for inducing HSC division, but the optimal cytokine combination to control self-renewal of HSC in vitro remains unclear. In this study, we compared the effects of interleukin-12 (IL-12) and thrombopoietin (TPO) in combination with stem cell factor (SCF) on in vitro self-renewal of HSCs. Single-cell assays were used to overcome the heterogeneity issue of HSCs, and serum-free conditions were newly established to permit reproduction of data. In single-cell cultures, CD150 + CD48 - CD41 - CD34 - c-Kit + Sca-1 + lineage - HSCs divided significantly more slowly in the presence of SCF+IL-12 compared with cells in the presence of SCF+TPO. Serial transplantation of cells from bulk and clonal cultures revealed that TPO was more effective than IL-12 at supporting in vitro self-renewal of short-term (<6 months) HSCs, resulting in a monophasic reconstitution wave formation, whereas IL-12 was more effective than TPO at supporting the in vitro self-renewal of long-term (>6 months) HSCs, resulting in a biphasic reconstitution wave formation. The control of division rate in HSCs appeared to be crucial for preventing the loss of self-renewal potential from their in vitro culture.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here